Australia Officially Debunks Homeopathy

Government researchers conclude that homeopathic therapies do not work.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, JAVIER MEDIAVILLA EZQUIBELA “There is no reliable evidence that homoeopathy is effective for treating health conditions.” That is the stark conclusion of the Australian government’s extensive review of the available scientific literature pertaining to homeopathic therapies, which use highly diluted formulas to treat numerous ills.

Australia’s National Health and Medical Research Council assessed studies on the effectiveness of homeopathy in treating 68 different conditions, including asthma, arthritis, cold and flu, chronic fatigue syndrome, eczema, cholera, malaria, and heroin addiction, and concluded that either the homeopathic treatment was no more effective than placebo or that there was insufficient evidence to suggest the homeopathic cure was more effective than that. “Homeopathic remedies contain nothing whatsoever,” University College London pharmacologist David Colquhoun told The Independent. “The Americans have spent $2 [billion] investigating these things . . . they haven’t found a single one that works.”

“Obviously we understand the placebo effect,” John Dwyer, an immunologist at the University of New South Wales, told The Guardian. “We know that many people have illnesses that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies